Oregon Health & Science University (3485 S. Bond)

Portland, Oregon 97239

1 studies enrolling now · 1 studies all time

What they study most

Clear Cell Renal Cell Carcinoma (ccRCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Studies at this site

• A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors — Recruiting now